A Clinical Program to Implement Repetitive Transcranial Magnetic Stimulation for Depression in the Department of Veterans Affairs.

Authors:
  • WCWhitney T Carrico
    Whitney T Carrico
  • GGGerald Georgette
    Gerald Georgette
  • MMMichelle R Madore
    Michelle R Madore
  • FKF Andrew Kozel
    F Andrew Kozel
  • MGMark S George
    Mark S George
  • SLSteven Lindley
    Steven Lindley
  • SLSteven Lovett
    Steven Lovett
  • JYJong H Yoon
    Jong H Yoon
Google Scholar
Abstract
Repetitive transcranial magnetic stimulation (rTMS) uses a device to create magnetic fields that cause electrical current to flow into targeted neurons in the brain. The most common clinical use of rTMS is for the treatment of major depressive disorder (MDD). The annual suicide rate of veterans has been higher than the national average; treating depression with rTMS would likely decrease suicide risk. MDD in many patients can be chronic and reoccurring with medication and psychotherapy providing inadequate relief. A pilot program was created to supply rTMS devices to 35 different sites in the VA nationwide in order to treat treatment-resistant depression. At time of analysis more than 950 veterans have started the program and 412 have finished. Nationwide, we have seen the depression scores decline, indicating an improvement in well-being. In addition, there is high patient satisfaction. Collecting data on a national level is a powerful way to examine rTMS efficacy and predictors of response which might be lost on a smaller subset of cases.

This publication has 20 references indexed in Scilit: